Molecular Partners AG (MOLN)
4.48
+0.20
(+4.67%)
USD |
NASDAQ |
Dec 11, 15:42
Molecular Partners Total Assets (Quarterly): 140.95M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 7.633B |
| AC Immune SA | 215.68M |
| CRISPR Therapeutics AG | 2.245B |
| Addex Therapeutics Ltd. | 9.205M |
| NewCelX Ltd. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.89M |
| Shareholders Equity (Quarterly) | 120.06M |
| Debt to Equity Ratio | 0.016 |
| Current Ratio | 9.280 |
| Net Debt Paydown Yield | 0.21% |